Olema Pharmaceuticals Stock Forecast
NASDAQ: OLMAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 7.82 0.00%
OLMA analyst consensus
Consensus (12 analysts)
none
Avg. price target
$36.50+366.75%
- Strong buy 2
- Buy 9
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 12 Wall Street analysts covering Olema Pharmaceuticals (2026-10-08), 11 rate the stock a buy or strong buy, 1 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $36.50, with a high estimate of $59.00 and a low estimate of $16.00. The average target implies upside of 366.8% from the current price of $7.82.
The spread between the highest and lowest targets is 268.8%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for OLMA.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 2 | 17% |
| Buy | 9 | 75% |
| Hold | 1 | 8% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $16.00 | +104.60% |
| Average target | $36.50 | +366.75% |
| High target | $59.00 | +654.48% |